220 related articles for article (PubMed ID: 21417506)
1. Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008.
Saokaew S; Suwankesawong W; Permsuwan U; Chaiyakunapruk N
Drug Saf; 2011 Apr; 34(4):339-50. PubMed ID: 21417506
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database.
Suwankesawong W; Saokaew S; Permsuwan U; Chaiyakunapruk N
BMC Complement Altern Med; 2014 Dec; 14():515. PubMed ID: 25539642
[TBL] [Abstract][Full Text] [Related]
3. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
[TBL] [Abstract][Full Text] [Related]
4. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
Star K; Norén GN; Nordin K; Edwards IR
Drug Saf; 2011 May; 34(5):415-28. PubMed ID: 21513364
[TBL] [Abstract][Full Text] [Related]
5. Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®.
Pokladnikova J; Meyboom RH; Meincke R; Niedrig D; Russmann S
Drug Saf; 2016 May; 39(5):455-64. PubMed ID: 26936182
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
[TBL] [Abstract][Full Text] [Related]
7. Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase
Meincke R; Pokladnikova J; Straznicka J; Meyboom RHB; Niedrig D; Russmann S; Jahodar L
Pediatr Allergy Immunol; 2017 Nov; 28(7):668-674. PubMed ID: 28846157
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
9. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
[TBL] [Abstract][Full Text] [Related]
10. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.
Lima EDC; Matos GC; Vieira JML; Gonçalves ICDCR; Cabral LM; Turner MA
J Pediatr (Rio J); 2019; 95(6):682-688. PubMed ID: 30030984
[TBL] [Abstract][Full Text] [Related]
11. Natural Health Product-Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication.
Mazhar H; Foster BC; Necyk C; Gardiner PM; Harris CS; Robaey P
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):38-47. PubMed ID: 31670573
[No Abstract] [Full Text] [Related]
12. Surveillance of suspected adverse reactions to natural health products in Italy.
Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867
[TBL] [Abstract][Full Text] [Related]
13. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems.
Gatti M; Ippoliti I; Poluzzi E; Antonazzo IC; Moro PA; Moretti U; Menniti-Ippolito F; Mazzanti G; De Ponti F; Raschi E
Clin Nutr; 2021 Mar; 40(3):1176-1185. PubMed ID: 32778460
[TBL] [Abstract][Full Text] [Related]
14. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.
Jacobsson I; Jönsson AK; Gerdén B; Hägg S
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1039-47. PubMed ID: 19650152
[TBL] [Abstract][Full Text] [Related]
15. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017.
Steyn H
S Afr Med J; 2023 Jun; 113(6):26-33. PubMed ID: 37278262
[TBL] [Abstract][Full Text] [Related]
16. Suspected adverse reactions associated with herbal products used for weight loss: spontaneous reports from the Italian Phytovigilance System.
Mazzanti G; Vitalone A; Da Cas R; Menniti-Ippolito F
Eur J Clin Pharmacol; 2019 Nov; 75(11):1599-1615. PubMed ID: 31428816
[TBL] [Abstract][Full Text] [Related]
17. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
18. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
Kunac DL; Tatley MV
Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
[TBL] [Abstract][Full Text] [Related]
19. Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre.
Star K; Sandberg L; Bergvall T; Choonara I; Caduff-Janosa P; Edwards IR
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):680-689. PubMed ID: 30767342
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
